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We report a novel mutation in a case of epidermo-
lytic hyperkeratosis that results in a proline for argi-
nin.e substitution in the penultimate residue position 
of the Hi subdomain of the keratin i chain, which is 
near the b e ginning of the rod domain. This causes a 
severe clinical disease classified as PS-2. Therefore, 
the Ht subdOinain is probably equally iL1.l.portant for 
the maintenance of keratin intermediate filament 
-
E pidermolytic hyperkeratosis (EHK) is a rare, autosomal dominantly inheJ'ited disorder of cornifi cation w ith a preva lence of 1 in 100,000 to 300,000 neonates. It presents at birth with blistering and erythema and is chara cterized by erosions and hyperkeratosis w it h in-
creasing age. Histopathologically , th e spinous and granular layers of 
the epidennis are disrupted by vacuolar degeneration caused by 
clumping of the keratin in termediate filaments (KJF) (Ishida-
Yamamoto eI II I, 1992; Bale eI III, 1993; DiGiovanna and Bale, 
1994a , 1994b; Huber Clll l , 1994). Recent studies have established 
that this disorder is ca used by mutations in either the ke ratin 1 or 10 
gene, w hich result in inappropriate am ino acid substitutions in the 
K.l or K10 proteins (Vassar ef nl , 1991; C hipev ef nl, 1992; Fuchs, 
1992; Fuchs el II I , 1992; rshida-Yamamoto el aI, 1992; Letai cf "I, 
1992; Rothnagel cf aI, 1992; Ba le el III, 1993; Steinert, 1993; 
Steinert eI III, 19933, 1993b; Chipev et II I , '1994: Compton, 1994; 
DiGiovanm' and Bale. 199401, 1994b; Fuchs and Weber, 1994; 
Hu b e r et nl, 1994; Rothnagel ci til, 1994; Syder el III, 1994; Y,mg et 
ai, 1994; McLean and Lane, 1995; Parry and Steinert, 1995; C hipev 
et ai, 1996). Most known deleterious substitutions reside in the rod 
domain portion of these chains. A few substitutions have been 
described in the HI domain located immediately prior to the 1 A rod 
subdomain. Recent structural studies have su ggested that the end of 
the rod domain and the neighborin g HI domain specify the correct 
alignment of neighboring protein chaiJls in lUF (Steinert el nl , 
1993a, 1993b; Fuchs and W eber, 1994; Parry and Steinert, 1995). 
The tissue degeneration presumably arises because these f.1u lt), 
proteins are unable to form functionaJ ly norl11al ]UF. Clinically. 
twO different types of EHK have been identified: PS, the presence 
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integrity as the rod domain. Since earlier concepts 
had implied that mutations in the Hi subdomain 
produce milder disease, this case suggests that at-
tempts to correlate mutations with disease presenta-
tion remain problematic. Key 1V00'ds: type II keratin/H1 
sJlbdolllai"/iclrthyosis. ] l1west D emratol 107:439-441, 
1996 
of palmarplantar scaling; and NPS, no palmarpJan tar scaling. Each 
of these was further subdivided depending on the rype and severity 
of scale (DiGiovanna and Bale, 1994a, 1994b). When correlated 
with the mutated kerati.n gene, it appears that the PS subtypes are 
due predominantly to keratin 1, whereas the NPS subtypes are due 
to keratin 10 (Compton, 1994; DiGiovanna and Bale, 1994a, 
1994b) . As predicted £i'om ;11 ,' ;Im and tran sgenic work (Vassar el lll, 
1991; Fuchs 1'1 II I, 1992; Syder el III , 1994) , the few known 
substitutions in the H1 subdomain resulted in a less severe PS- l 
clinical presentation thall th ose located in the begil1ning of the 1 A 
or end of2B rod domain segments, which are usu ally PS-2 or PS-3 
(Compton , 1994; McLean and Lan e, '\ 995). In this paper, we 
describe a new case of severe EHK. classified as PS-2, ca used by a 
substitution in HI. 
MATERl ALS AND METHODS 
Source of DNA DNA was isolated :1S described (Chipcv £1 aI, 1994 ; 
Yang £, al. 1994) Ii-om freshly drawn blood obtained from both allc ted and 
unaffected family tnembers. Genomic DNA was also extracted from 50 
ullrelared normal individuals of similar ethnic background used as controls. 
Direct Polymerase Chain Reaction AIllplification a.nd Sequencing 
of the Keratin 1 Gene The o ligonucleotide primers used tor ampli fying 
exon 1 ofK1 were: GII ( + ) , 5 ' -TTTGGTGCTGGTGGTGGATTT-3 '; and 
4n (- ), 5'-TGCGTGTGTTTTGACTGCACCGAT-3'. T he latter was also 
used as a sequencing primer, using the single- stranded binding protein 
(United States Biochemical Corp .. Cleveland. OH) (Yang rt ai, 1994). 
KIF Disassembly Assay with Synthetic Pep tides Several peptides 
(see Table I) were synthesized and purified. T hese were added in a 1- to 
2-fold molar excess to Kl / K l 0 Kllo and incubated for 60 min at 37°C . and 
the results Oil KIF integrity were examined by turbidity as described 
previously (Chipe" CI ai, 1992; Steinert cl ai, 1993a. 1993 b). 
RESULTS AND DISCUSSION 
Clinical Description of Family EHK-SMC The diagnosis of 
EHK was confinned by histopathology obtained frOI11 skin biopsy 
specimen s. T his f.1lTIi ly consisted of single patient and her elder 
sister and unaffected parents; i.e., this is likely to be a new sporadic 
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Table l. Peptide Disassembly Assay 
'Yo Light scattering 
Human keratin 1 peplide sequences used" remaining" 
1 N o peptide 
2 Wi ld typc HI 
3 Wildtype short H1 
4 Mutant HI 
5 Mutant short HI 
6 Wild type IA 
PVCPPGGIQEVTINQSLLQPLNVEIDPEIQKVKSRE 
IQEVTINQSLLQPLNVEIDPEIQKVKSRE 
PVCPPGGIQEVTINQSLLQPLNVEIDPEIQKVKSPE 
IQEVTINQSLLQPLNVEIDPEIQKVKSPE 
97 :':: 4 
4 :': 2 
5 :':: 3 
9 :': 3 
7 :':: 4 
3 :':: 1 
3 :': 2 7 W ildtype short HI + w ildtype lA 
8 Mutant short HI + wildtype 1 A 
REQIKSLNNQFASFIDKVRF 
IQEVTINQSLLQPLNVEIDPEIQKVKSRE REQIKSLNNQFASFIDKVRF 
IQEVTINQSLLQPLNVEIDPEIQKVKSPE REQIKSLNNQFASPIDKVRF 89 :':: 8 
II The dat:t arc the average ± SI) of three to five separate m easurements. 
II The P in bold identifies the proline substitution in ;1 region predic ted to form an a-helix (but not co iled-coil) at the penultimate res idue position of th e 1-1 I subdo1l1ilin. 
case (Fig 1a). Because she had moderate to severe thick scaly 
patches with erythema on her entire body, including palms and 
soles, as well as mild digital contractures, this case was classified 
PS-2 or perhaps borderline PS-1. 
Identification of an Arginine to Proline Substitution in the 
H1 Subdomain W e found no sequence variations from normal 
in all exons of the K10 gene . In the Kl gene, however, we found 
a single nucleotide substitution in one allele in the affected child 
(CGA to CCA) so that the sequence gel of Fig Ib shows both a 
wild type G and a mutant C in position 2 of codon 178. T he mutant 
allele encodes a proUne residue instead of a wild type arginine 
residue in position 35 of the HI subdomain. T his nucleotide 
substitution destroys an X /wI restriction enzyme site (CTCGAG) , 
which was then used as a test for the presence of the mutation in 
polymerase chain reaction-amplified DNA. In this analysis, the 
nonnal alleles yield fragments of 368 and 132 bp , but the affected 
allele yields fragm ents of 500, 368, and 1.32 bp (Fig lc) . Because 
none of the other three family members and 50 other unrela ted 
unaffected persons display the X/IOI undigested fragment, the G to 
C substitution in the affected child represents a new mutation. 
The Proline Substitution Introduces Major Structural 
Change to the Keratin 1 Sequence We have devised an ill 
lIitro disa~sembly assay usin g synthetic pep tides corresponding to 
sequence domai.ns of keratins (Chipev et nI, 1992). Due to a 
competition reaction, wild type peptides disassemble the KIF in to 
small oligomers, but peptides with amino acid su bstitutions found 
in keratin diseases often compete less and , as a result, only partly 
disassemble the KIF. T he degree of disassembly is monitored by 
light scattering (turbidity). In tllis study, we found that both wild 
a I • 1 1·2 b 
JI - 2 
G 
5 · 
0 ~ R1 7 0/ P[ ~/C 
II - 1 11- 2 J . 
type and mutant full-l ength as w ell as short H1 synthe tic peptides 
caused virtually comple te disassembly of KUKIO KIF (Table I). 
Based on our earlier o bservations with this assay, i. e., substitutions 
located near the ends of syn thetic peptides often do not disassemble 
KIF ill lIitro (Steinert c/ ai, 1993b), however, we made longer 
peptides that span the junction of the HI and 1 A sequence region . 
In this case, the peptide bearing the proline substitution was 
essentially un able to disassemble the KIF (Table I) . T his means that 
the proline substitutio n at this res idue positio n does indeed impart 
a major stwctural chan ge to the synthe tic peptide and to the intact 
keratin 1 chain itsel f. From this, we can conclude that the KIF of 
th e mutant alle le of the patient are defective, which leads to the 
severe patho logy of PS-2 EHK. 
Complexity of Assignment of Disease Severity with Loca-
tion of Atnino Acid Substitutions Previous point mutational 
anal yses revealed that proline substitutions in end-domain se-
quences resulted in less severe consequences for KIF structure than 
su bstitutions in rod-domain sequences (Letai e( n/, 1992). T his 
concept was supported by the findings that substitu tions in the HI 
subdomain of the K1 or K5 chaills resul ted in less severe forms of 
pathology in EHK or EBS (Compton, 1994; McLean and Lane, 
1995) . This work, h owever, shows that HI substitu tions close to 
the beginning of the rod domain may also ca use a severe pheno-
type. Also in this regard , it has been noted that a very common 
substitution in the tenth residue position of the lA rod-domain 
segment of type I keratin chains (often R10 H) can lead to widell' 
differing degrees of severity in several types of kera tinopathies, 
including NPS-l, NPS-2 , or NPS-3 in EHK (Compton, 1994; 
M cLean and Lane, 1995) . T hi s means that other ullknown etiologic 
C 1 2 3 123 EHK-SMC 
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Figure L Characteristics ofEHK-SMC_ (a) Pedigree. (b) DNA sequences showing G to C change, which introduces;)n R1 78P :Imino :lcid substitution. 
(c) X/wI digestion of po lymerase chain reaction-amplified DNA of fami ly members. T he mutation abolishes an X /wI site in the patient. O nly the aflected 
individual sho ws the undigested SOO-bp fragments. 
voL. 107. NO.3 SEPTEMBER 19% 
fac tors Illu st al so influence dise;\se severi ty. T herefore, the associ-
ation o f disease p heno type w ith !nutatio n /substitu t io n location 
should be made with ca ution . 
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